Volume : 13, Issue : 10, October – 2026

Title:

EVALUATION AND PHOTOCHEMICAL SCREENING OF ANTIHYPERLIPIDEMIC ACTIVITY OF TERMINALIA ARJUNA

Authors :

Dr. R Ramya Krishna*, Dhara Pavithra, Konduti Poojitha, Kothapally Ajay Kumar, Mudangula Bhuvaneshwari, Dr. M. Srikanth

Abstract :

The present study was undertaken to evaluate the phytochemical constituents, antihyperlipidemic activity, and antioxidant potential of the ethanolic extract of Terminalia arjuna in high-fat diet (HFD)-induced hyperlipidemic rats. Preliminary phytochemical screening of the extract revealed the presence of flavonoids, tannins, phenolic compounds, saponins, glycosides, and triterpenoids, which are known for their therapeutic properties. Acute toxicity studies performed according to OECD guidelines indicated that the extract was safe at the tested dose levels.
Hyperlipidemia was induced in Wistar albino rats by administration of a high-fat diet for the experimental period. The animals were divided into five groups: normal control, hyperlipidemic control, standard drug-treated group, and two test groups receiving Terminalia arjuna ethanolic extract at doses of 200 mg/kg and 400 mg/kg respectively. Atorvastatin (10 mg/kg) was used as the standard drug. Various biochemical parameters including body weight, total cholesterol (TC), triglycerides (TG), HDL, LDL, VLDL, creatinine, urea, uric acid, AST, ALT, and ALP were evaluated. Antioxidant parameters such as superoxide dismutase (SOD), catalase, reduced glutathione (GSH), and lipid peroxidation (MDA) were also estimated.
The hyperlipidemic control group showed significant increases in body weight, serum lipid profile, liver enzyme markers, renal parameters, and lipid peroxidation levels, along with decreased HDL and antioxidant enzyme levels. Treatment with Terminalia arjuna extract significantly reduced TC, TG, LDL, VLDL, AST, ALT, ALP, creatinine, urea, uric acid, and MDA levels while increasing HDL, SOD, catalase, and GSH levels when compared with the hyperlipidemic control group. The high-dose extract (400 mg/kg) demonstrated greater pharmacological activity and produced results comparable to atorvastatin.
the study indicate that Terminalia arjuna possesses significant antihyperlipidemic and antioxidant activities, which may be attributed to the presence of bioactive phytoconstituents. Thus, the plant extract may serve as a potential natural therapeutic agent for the management of hyperlipidemia and associated oxidative stress.
Keywords: Hyperlipidemia, Terminalia arjuna, Antihyperlipidemic activity, Antioxidant activity, High-fat diet, Lipid profile, Flavonoids, Oxidative stress, Atorvastatin, Phytochemical screening.

Cite This Article:

Please cite this article in press R Ramya Krishna et al., Evaluation And Photochemical Screening Of Antihyperlipidemic Activity Of Terminalia Arjuna.,. Indo Am. J. P. Sci, 2026; 13(10).

REFERENCES:

1. Singh RB, Niaz MA, Ghosh S. Hypolipidemic and antioxidant effects of Commiphora mukul as an adjunct to dietary therapy in patients with hypercholesterolemia. Cardiovasc Drugs Ther. 1994;8(4):659-664.
2. Thompson-Coon J, Ernst E. Herbs for serum cholesterol reduction: a systematic review. J Fam Pract. 2003;52(6):468-478.
3. Silagy C, Neil A. A meta-analysis of the effect of garlic on serum lipids. J Fam Pract. 1994;38(2):158-162.
4. Gerards MC, Terlou RJ, Yu H, Koks CH, Gerdes VE. Red yeast rice for hyperlipidemia: a meta-analysis. Atherosclerosis. 2015;240(2):415-423.
5. Heshmat-Ghahdarijani K, Mashayekhiasl N, Amerizadeh A, et al. Effect of fenugreek consumption on serum lipid profile: a systematic review and meta-analysis. Phytother Res. 2020;34(9):2230-2245.
6. Ansary J, Forbes-Hernández TY, Gil E, Cianciosi D, Zhang J, Elexpuru-Zabaleta M, et al. Potential health benefit of garlic. Nutrients. 2020;12(6):1-28.
7. Sharma MS, Choudhary PR. Effect of fenugreek seeds on hyperlipidemia in rabbits. J Diet Suppl. 2017;14(1):1-8.
8. Takkella N, Konuri A, Nayak CD, et al. Fenugreek seed extract in high-fat diet rats. J Taibah Univ Med Sci. 2019;14(4):383-389.
9. Nematollahi S, Pishdad GR, Zakerkish M, et al. The effect of berberine and fenugreek seed co-supplementation on lipid profile in type 2 diabetes mellitus: a randomized clinical trial. Diabetol Metab Syndr. 2022;14:120.
10. Studies documenting Allium sativum (garlic) for lipid lowering — pooled RCT data (multiple sources summarized in reviews above).
11. Classic experiments on Commiphora mukul lipid effects — see Satyavati GV et al., Indian J Med Res. 1969;50:1950-1955.
12. Gylling H, Plat J, Turley S, et al. Plant sterols and stanols in the management of dyslipidemia and prevention of cardiovascular disease. Atherosclerosis. 2014;232:346-360.
13. Abumweis SS, Barake R, Jones PJH. Plant sterols/stanols as cholesterol lowering agents: a meta-analysis of randomized controlled trials. J Clin Lipidol. 2008;2(2):199-208.
14. Katan MB, Grundy SM, Jones P, Law M, Miettinen T, Paoletti R. Efficacy and safety of plant stanols and sterols in the management of blood cholesterol levels. Mayo Clin Proc. 2003;78(8):965-978.
15. Plat J, Mensink RP. Plant stanol and sterol esters in the control of blood cholesterol levels: mechanism and safety aspects. Am J Cardiol. 2002;90(10C):50G-58G.
16. Visavadiya NP, Narasimhacharya AVRL. Hypolipidemic and antioxidant effects of functional foods. J Sci Food Agric. 2008;88(11):1879-1883.
17. Park J, et al. Hypolipidemic effect of Cynara scolymus (artichoke) extract in animals. J Med Food. 2009;12(3):558-564.
18. Gardner CD, et al. Effect of various garlic preparations on lipid profiles: systematic evaluation. J Nutr. 2007;137(3 Suppl):792S-799S.
19. Rouhi-Boroujeni H, et al. Medicinal herbs with hypolipidemic effects: mechanisms and clinical evidence. Phytother Res. 2017;31(11):1671-1687.
20. Mehraban S, et al. Systematic review of meta-analyses on herbal medicines for dyslipidemia. Phytother Res. 2021;35(10):5803-5817.
21. Sedighi M, et al. Phytochemicals with potential in lipid control and atherosclerosis prevention. J Ethnopharmacol. 2017;198:373-397.
22. Parikh P, et al. Indigenous medicinal plants used to treat metabolic syndrome components including dyslipidemia: a review. J Ethnopharmacol. 2014;155(2):1010-1020.
23. Fossati P, Prencipe L. Serum triglycerides determined colorimetrically with an enzyme that produces hydrogen peroxide. Clinical Chemistry. 1982;28(10):2077–2080.
24. Burstein M, Scholnick HR, Morfin R. Rapid method for the isolation of lipoproteins from human serum by precipitation with polyanions. Journal of Lipid Research. 1970;11(6):583–595.
25. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge. Clinical Chemistry. 1972;18(6):499–502.
26. Jaffe M. Über den Niederschlag welchen Pikrinsäure in normalem Harn erzeugt und über eine neue Reaction des Kreatinins. Zeitschrift für Physiologische Chemie. 1886;10:391–400.
27. Fawcett JK, Scott JE. A rapid and precise method for the determination of urea. Journal of Clinical Pathology. 1960;13:156–159.
28. Caraway WT. Determination of uric acid in serum by a carbonate method. American Journal of Clinical Pathology. 1955;25(7):840–845.
29. Reitman S, Frankel S. A colorimetric method for the determination of serum glutamic oxaloacetic and glutamic pyruvic transaminases. American Journal of Clinical Pathology. 1957;28(1):56–63.
30. Kind PRN, King EJ. Estimation of plasma phosphatase by determination of hydrolyzed phenol with amino-antipyrine. Journal of Clinical Pathology. 1954;7(4):322–326.
31. Misra HP, Fridovich I. The role of superoxide anion in the autooxidation of epinephrine and a simple assay for superoxide dismutase. Journal of Biological Chemistry. 1972;247(10):3170–3175.